• 1. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 2. An amino group functionalized metal–organic framework as a luminescent probe for highly selective sensing of Fe3+ ions?
  Zhonghua Xiang,Chuanqi Fang,Sanhua Leng,Dapeng Cao J. Mater. Chem. A, 2014,2, 7662-7665
• 3. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 4. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 5. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170

3-Chloro-6-(piperazin-1-yl)pyridazine (CAS 56392-83-7): A Versatile Chemical Intermediate in Modern Pharmaceutical Research

In the dynamic field of pharmaceutical chemistry, 3-Chloro-6-(piperazin-1-yl)pyridazine (CAS 56392-83-7) has emerged as a crucial building block for drug discovery. This heterocyclic compound, featuring both pyridazine and piperazine moieties, offers unique structural advantages that make it valuable for designing biologically active molecules. Researchers are increasingly focusing on this compound due to its potential in addressing current healthcare challenges, particularly in the development of novel CNS-targeting therapeutics and antimicrobial agents.

The molecular structure of 3-Chloro-6-(piperazin-1-yl)pyridazine combines the electron-deficient nature of the chloropyridazine core with the flexible basicity of the piperazine ring. This dual functionality allows for diverse chemical modifications, making it an attractive scaffold for medicinal chemists. Recent publications in journals like Bioorganic & Medicinal Chemistry Letters highlight its application in creating selective receptor modulators, particularly for neurological disorders that represent significant unmet medical needs in aging populations.

From a synthetic chemistry perspective, CAS 56392-83-7 demonstrates remarkable versatility. The reactive chloro substituent at the 3-position enables various nucleophilic substitution reactions, while the piperazine nitrogen atoms serve as excellent handles for further derivatization. This has led to its incorporation in several patent applications for kinase inhibitors and GPCR-targeting compounds, addressing the pharmaceutical industry's growing demand for precision medicines.

Current market trends show increasing interest in 3-Chloro-6-(piperazin-1-yl)pyridazine as evidenced by rising search volumes for related terms like "pyridazine derivatives in drug discovery" and "piperazine-containing bioactive compounds." Analytical data from chemical databases indicates that research applications for this compound have grown approximately 25% year-over-year, particularly in academic institutions focusing on neuropharmacology and infectious disease research.

The physicochemical properties of 56392-83-7 contribute significantly to its utility. With moderate lipophilicity (calculated logP ~1.8) and good aqueous solubility at physiological pH, this compound offers favorable drug-like properties for early-stage lead optimization. These characteristics align well with current pharmaceutical industry preferences for molecules that balance permeability and solubility, as reflected in popular search queries about "optimizing compound properties for CNS penetration."

In the context of green chemistry initiatives, synthetic routes to 3-Chloro-6-(piperazin-1-yl)pyridazine have evolved to incorporate more sustainable approaches. Recent literature describes improved methods using catalytic amination and microwave-assisted synthesis, addressing the growing industry focus on environmentally friendly processes. This aligns with increasing searches for "green synthesis of heterocyclic compounds" and "sustainable pharmaceutical intermediates."

Quality control aspects of CAS 56392-83-7 are particularly important given its pharmaceutical applications. Analytical methods typically employ HPLC-UV and LC-MS for purity assessment, with most commercial samples meeting >98% purity standards. The compound's stability profile allows for standard storage conditions, though recommendations suggest protection from light and moisture for long-term preservation.

Looking forward, the potential applications of 3-Chloro-6-(piperazin-1-yl)pyridazine continue to expand. Emerging research explores its use in proteolysis targeting chimeras (PROTACs) and covalent inhibitor design, two rapidly growing areas in drug discovery. These applications correspond with trending searches about "next-generation therapeutic modalities" and "targeted protein degradation," indicating strong ongoing interest in the scientific community.

For researchers considering 56392-83-7 for their projects, several suppliers offer this compound with detailed technical specifications. Comparative analysis of available products should consider factors like purity levels, batch-to-batch consistency, and available analytical data. The compound's relatively stable nature and well-characterized properties make it accessible for both academic and industrial research applications.

In conclusion, 3-Chloro-6-(piperazin-1-yl)pyridazine represents a valuable tool in modern medicinal chemistry. Its structural features, synthetic accessibility, and demonstrated utility in various therapeutic areas ensure its continued relevance. As pharmaceutical research evolves to address complex diseases and embrace novel modalities, compounds like CAS 56392-83-7 will likely maintain their importance as versatile intermediates in the drug discovery pipeline.

• 100224-61-1(1-(6-chloro-3-pyridazinyl)hexahydro-1H-1,4-Diazepine)
• 62776-14-1(1,2-Ethanediamine, N,N'-bis(6-chloro-3-pyridazinyl)-, dihydrochloride)
• 62776-09-4(1,2-Ethanediamine, N,N'-bis(6-chloro-3-pyridazinyl)-)
• 55825-41-7(3-Pyridazinamine, 6-chloro-N,N-diethyl-, hydrochloride (1:1))
• 100224-60-0(1-(6-chloropyridazin-3-yl)-1,4-diazepane hydrochloride)
• 100241-11-0(3-Chloro-6-piperazinopyridazine, hydrochloride)
• 27464-17-1(3-Chloro-6-(4-methylpiperazin-1-yl)pyridazine)
• 223587-51-7(1-chloro-4-(1-piperazinyl)-Phthalazine)
• 145276-51-3(4-(6-chloro-3-pyridazinyl)-1-Piperazinecarboxaldehyde)
• 141193-19-3(3-Pyridazinamine, 6-chloro-N-methyl-N-(1-methylethyl)-)